Srs Capital Advisors, Inc. Hutchmed (China) LTD Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 103 shares of HCM stock, worth $1,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103
Previous 103
-0.0%
Holding current value
$1,666
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HCM
# of Institutions
70Shares Held
6.77MCall Options Held
8.2KPut Options Held
9.2K-
Schroder Investment Management Group London, X02.77MShares$44.8 Million0.04% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.12MShares$18.2 Million0.02% of portfolio
-
Ubs Group Ag378KShares$6.11 Million0.0% of portfolio
-
State Street Corp Boston, MA348KShares$5.62 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$5.1 Million0.12% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.8B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...